DRG为何这么“火”?细说DRG对医院绩效管理的冲击

2018-12-11 佚名 医院绩效管理

DRG

DRG医保支付制度改革真的“狼来了”,DRG到底是什么?DRG医保支付为何要用它?DRG对医院到底意味着什么?DRG对医院绩效管理带来什么冲击?DRG医保支付医院绩效管理如何变革调整适应?笔者用连载的方式“细说DRG对医院绩效管理冲击”,今天第一篇讲一下《DRG为何这么“火”》。DRG成为医保支付改革的重要工具,全面推广执行在即,医院也在为应对DRG厉兵秣马,药企商家也在为DRG绞尽脑汁,医生在为

DRG医保支付制度改革真的“狼来了”,DRG到底是什么?DRG医保支付为何要用它?DRG对医院到底意味着什么?DRG对医院绩效管理带来什么冲击?DRG医保支付医院绩效管理如何变革调整适应?笔者用连载的方式“细说DRG对医院绩效管理冲击”,今天第一篇讲一下《DRG为何这么“火”》。

DRG成为医保支付改革的重要工具,全面推广执行在即,医院也在为应对DRG厉兵秣马,药企商家也在为DRG绞尽脑汁,医生在为DRG而苦恼,患者也在为DRG而担忧,DRG现在越来越火,正在演奏爱恨交响曲,一句话“DRG,爱你不容易”。

DRG到底是什么?

DRGs (DiagnosisRelatedGroups)称为诊断相关分组,是一种病人分类方案,是专门用于医疗保险预付款制度的分类编码标准。它根据出院病历为依据,综合考虑了患者的主要诊断和主要治疗方式,结合个体特征如年龄、并发症和伴随病,根据疾病的复杂程度和费用将相似的病例分到同一个组中,给予定额预付款。

认识DRG,还得从美国说起,第一代DRGs系统于1967年由美国耶鲁大学Robert B. Fetter及其团队开发(下称“Yale DRGs”),1970年,Yale DRGs在美国新泽西州的支付制度试点改革中应用。目前全世界应用DRGs的国家已经超过30个。

我国有,北京版DRGs(BJ-DRGs),其主要“师承”的是美国的AP-DRGs和澳大利亚的AR-DRGs。还有CN-DRGs分组方案(2014版),最终将所有病例分为783个DRGs。还有地方探索版。目前还没有正式确定国家版,预计2019年将会有国家正式版。

揭开DRG神秘的“面纱”

DRG为何“太神秘”,由于国家也在积极试点,各地也在探索,还不能拿出一个行业权威认可的“国标版DRG”,因为研究DRG需要人财物力较大的投入,卫健委、医保局、医院都有不同的看法和想法,还没有达成共识,加之DRG作为新兴事物,从学术研究方面、政治方面、试点方面,DRG好东西显得很神秘,各方都高度关注,自然产生政治价值、商业价值、垄断价值等极高的价值,为DRG推动注入强劲的动力。

直白地说,单病种付费是按照一种疾病一个价格支付医保费用,DRG是按照分组规则把同质化相近的一组病种归类,成为一个付费单位。按照一组疾病付费,这就涉及到DRG相关疾病分组规则的确定,支付结算规则的制定,也就是说,同一个疾病组支付结算价格涉及到RW、CMI、时间效率指数、费用消耗指数、风险死亡率等五大因素。

DRG为何这么火?

医保付费制度改革紧锣密鼓,从2016年开始密集出台了一系列与医保支付方式改革有关的政策,推动了DRG研究、探索、试点等“火起来”。

1.政策推动DRG要火起来

国办发〔2017〕55号《关于进一步深化基本医疗保险支付方式改革的指导意见》明确提出,各地要选择一定数量的病种实施按病种付费,国家选择部分地区开展按疾病诊断相关分组(DRGs)付费试点,鼓励各地完善按人头、按床日等多种付费方式。到2020年,医保支付方式改革覆盖所有医疗机构及医疗服务,全国范围内普遍实施适应不同疾病、不同服务特点的多元复合式医保支付方式,按项目付费占比明显下降。

时间紧任务重,政策推动, DRG作为医保支付方式改革的主要手段,必然借助政策东风“火”起来。

2.医保基金控费所需决定DRG要火

由于我国全面医保制度,实行的是“低水平、广覆盖、保重点”的原则,筹资水平比较低,医保基金的有限性,医保基金总量不足,与民众对健康医疗消费需求与医院对收入驱动的无限性,随着人口老龄化、疾病谱变化三者之间的矛盾日益突出和尖锐,医保基金“串底”风险大增。医保是重大的民生,涉及到社会的和谐稳定,如何用有限性的医保资金,解决大众的医疗看病问题,医保基金要“平衡” DRG作为医保控费工具自然选用,DRG熊熊之火必然漫卷西风。

3.应对医院增收驱动DRG要火

医院作为医疗服务提供方,面对传统的医保后付费制度,医院多开药、多检查等过度医疗刺激医院增收驱动,让医保“头痛”,医保支付改革成DRG预付费制度,对医院增收具有重大的限制作用,涉及到医院的“钱袋子”,影响到医院的发展可持续性,医院必须认真学习和领会DRG,不研究未来会让医院头痛,所以DRG必然会“火起来”。

总之,单病种付费制度探路先行,为DRG点燃了“星星之火”,国家医疗保障局的成立,国标版DRG必然到来,DRG必然“燎原”,是医保控费必然的选择,医院必须未雨绸缪,也必然倒逼医院绩效迭代升级。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1935756, encodeId=06711935e5673, content=<a href='/topic/show?id=4e8d35582d0' target=_blank style='color:#2F92EE;'>#医院绩效#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35582, encryptionId=4e8d35582d0, topicName=医院绩效)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac782500066, createdName=12498768m13(暂无昵称), createdTime=Fri Nov 22 04:06:00 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2052799, encodeId=7ff92052e992a, content=<a href='/topic/show?id=58b4e90014c' target=_blank style='color:#2F92EE;'>#绩效管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79001, encryptionId=58b4e90014c, topicName=绩效管理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec25412, createdName=yangpeizhi, createdTime=Mon Oct 14 03:06:00 CST 2019, time=2019-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1322850, encodeId=6611132285083, content=<a href='/topic/show?id=0c5d62457e' target=_blank style='color:#2F92EE;'>#DRG#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6245, encryptionId=0c5d62457e, topicName=DRG)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dcaa509, createdName=tsing_hit, createdTime=Thu Dec 13 11:06:00 CST 2018, time=2018-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1523887, encodeId=7d58152388ecf, content=<a href='/topic/show?id=123ee8990b8' target=_blank style='color:#2F92EE;'>#绩效#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78990, encryptionId=123ee8990b8, topicName=绩效)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=604311562575, createdName=whlxd, createdTime=Thu Dec 13 11:06:00 CST 2018, time=2018-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=355142, encodeId=035235514259, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Tue Dec 11 20:37:04 CST 2018, time=2018-12-11, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1935756, encodeId=06711935e5673, content=<a href='/topic/show?id=4e8d35582d0' target=_blank style='color:#2F92EE;'>#医院绩效#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35582, encryptionId=4e8d35582d0, topicName=医院绩效)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac782500066, createdName=12498768m13(暂无昵称), createdTime=Fri Nov 22 04:06:00 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2052799, encodeId=7ff92052e992a, content=<a href='/topic/show?id=58b4e90014c' target=_blank style='color:#2F92EE;'>#绩效管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79001, encryptionId=58b4e90014c, topicName=绩效管理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec25412, createdName=yangpeizhi, createdTime=Mon Oct 14 03:06:00 CST 2019, time=2019-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1322850, encodeId=6611132285083, content=<a href='/topic/show?id=0c5d62457e' target=_blank style='color:#2F92EE;'>#DRG#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6245, encryptionId=0c5d62457e, topicName=DRG)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dcaa509, createdName=tsing_hit, createdTime=Thu Dec 13 11:06:00 CST 2018, time=2018-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1523887, encodeId=7d58152388ecf, content=<a href='/topic/show?id=123ee8990b8' target=_blank style='color:#2F92EE;'>#绩效#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78990, encryptionId=123ee8990b8, topicName=绩效)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=604311562575, createdName=whlxd, createdTime=Thu Dec 13 11:06:00 CST 2018, time=2018-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=355142, encodeId=035235514259, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Tue Dec 11 20:37:04 CST 2018, time=2018-12-11, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1935756, encodeId=06711935e5673, content=<a href='/topic/show?id=4e8d35582d0' target=_blank style='color:#2F92EE;'>#医院绩效#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35582, encryptionId=4e8d35582d0, topicName=医院绩效)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac782500066, createdName=12498768m13(暂无昵称), createdTime=Fri Nov 22 04:06:00 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2052799, encodeId=7ff92052e992a, content=<a href='/topic/show?id=58b4e90014c' target=_blank style='color:#2F92EE;'>#绩效管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79001, encryptionId=58b4e90014c, topicName=绩效管理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec25412, createdName=yangpeizhi, createdTime=Mon Oct 14 03:06:00 CST 2019, time=2019-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1322850, encodeId=6611132285083, content=<a href='/topic/show?id=0c5d62457e' target=_blank style='color:#2F92EE;'>#DRG#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6245, encryptionId=0c5d62457e, topicName=DRG)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dcaa509, createdName=tsing_hit, createdTime=Thu Dec 13 11:06:00 CST 2018, time=2018-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1523887, encodeId=7d58152388ecf, content=<a href='/topic/show?id=123ee8990b8' target=_blank style='color:#2F92EE;'>#绩效#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78990, encryptionId=123ee8990b8, topicName=绩效)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=604311562575, createdName=whlxd, createdTime=Thu Dec 13 11:06:00 CST 2018, time=2018-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=355142, encodeId=035235514259, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Tue Dec 11 20:37:04 CST 2018, time=2018-12-11, status=1, ipAttribution=)]
    2018-12-13 tsing_hit
  4. [GetPortalCommentsPageByObjectIdResponse(id=1935756, encodeId=06711935e5673, content=<a href='/topic/show?id=4e8d35582d0' target=_blank style='color:#2F92EE;'>#医院绩效#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35582, encryptionId=4e8d35582d0, topicName=医院绩效)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac782500066, createdName=12498768m13(暂无昵称), createdTime=Fri Nov 22 04:06:00 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2052799, encodeId=7ff92052e992a, content=<a href='/topic/show?id=58b4e90014c' target=_blank style='color:#2F92EE;'>#绩效管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79001, encryptionId=58b4e90014c, topicName=绩效管理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec25412, createdName=yangpeizhi, createdTime=Mon Oct 14 03:06:00 CST 2019, time=2019-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1322850, encodeId=6611132285083, content=<a href='/topic/show?id=0c5d62457e' target=_blank style='color:#2F92EE;'>#DRG#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6245, encryptionId=0c5d62457e, topicName=DRG)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dcaa509, createdName=tsing_hit, createdTime=Thu Dec 13 11:06:00 CST 2018, time=2018-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1523887, encodeId=7d58152388ecf, content=<a href='/topic/show?id=123ee8990b8' target=_blank style='color:#2F92EE;'>#绩效#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78990, encryptionId=123ee8990b8, topicName=绩效)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=604311562575, createdName=whlxd, createdTime=Thu Dec 13 11:06:00 CST 2018, time=2018-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=355142, encodeId=035235514259, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Tue Dec 11 20:37:04 CST 2018, time=2018-12-11, status=1, ipAttribution=)]
    2018-12-13 whlxd
  5. [GetPortalCommentsPageByObjectIdResponse(id=1935756, encodeId=06711935e5673, content=<a href='/topic/show?id=4e8d35582d0' target=_blank style='color:#2F92EE;'>#医院绩效#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35582, encryptionId=4e8d35582d0, topicName=医院绩效)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac782500066, createdName=12498768m13(暂无昵称), createdTime=Fri Nov 22 04:06:00 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2052799, encodeId=7ff92052e992a, content=<a href='/topic/show?id=58b4e90014c' target=_blank style='color:#2F92EE;'>#绩效管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79001, encryptionId=58b4e90014c, topicName=绩效管理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec25412, createdName=yangpeizhi, createdTime=Mon Oct 14 03:06:00 CST 2019, time=2019-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1322850, encodeId=6611132285083, content=<a href='/topic/show?id=0c5d62457e' target=_blank style='color:#2F92EE;'>#DRG#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6245, encryptionId=0c5d62457e, topicName=DRG)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dcaa509, createdName=tsing_hit, createdTime=Thu Dec 13 11:06:00 CST 2018, time=2018-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1523887, encodeId=7d58152388ecf, content=<a href='/topic/show?id=123ee8990b8' target=_blank style='color:#2F92EE;'>#绩效#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78990, encryptionId=123ee8990b8, topicName=绩效)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=604311562575, createdName=whlxd, createdTime=Thu Dec 13 11:06:00 CST 2018, time=2018-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=355142, encodeId=035235514259, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Tue Dec 11 20:37:04 CST 2018, time=2018-12-11, status=1, ipAttribution=)]
    2018-12-11 医者仁心5538

    学习了

    0

相关资讯

浅析DRG在医保支付中的应用

按照DRG相关疾病组医保支付,是今后发展的大趋势。建立DRGs-PPS为主流的医保支付制度,有助于最终实现医保基金支出可控、医院控费有动力、服务质量有保障、参保人群得实惠的多方共赢的医改目标。

DRG收付费制度改革 医院绩效工资制度应对策略

面对DRG医保支付制度改革,传统的收支结余提取绩效工资制度,明显不能适应新形势新要求。DRG医保支付制度改革,针对病种付费,单纯的科室成本核算方法明显不适应,需要病种成本核算相配套。医保制度的变革,必然影响医院绩效工资分配制度变革,DRG病种绩效工资核算制度如何应对,成为医院管理者关注的焦点。1.消极应对——逆向选择面对DRG医保支付制度改革,也许医院会选择消极应对,开始抵制,会逆向选择推诿病人,

我国启动DRG收付费改革试点 C-DRG将成医院收付费新标准

国家卫计委启动DRG收付费改革试点,2019年有望将试点扩大到50个城市,2020年扩大到100个城市。

云南DRG改革走出禄丰

医保支付方式改革撬动医改全局。作为全国15个深化医改典型之一,云南省禄丰县探索DRG支付方式改革(按疾病诊断组付费)的经验开始在该省逐步推广。

诸任之:DRG推行的基础是医生要有高收入

DRGs从诞生开始就是一个省钱的工具,不是一个挣钱的方法。